Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7050242 | 0.81 | SHBG (0.40) | SHBG | |
| SCHEMBL21168604 | 0.76 | SHBG (0.50) | SHBG | |
| SCHEMBL22435492 | 0.76 | SHBG (0.50) | SHBG | |
| SCHEMBL18790619 | 0.76 | SHBG (0.50) | SHBG | |
| SCHEMBL7056761 | 0.75 | ALOX5 (0.35) | — | |
| SCHEMBL27644567 | 0.71 | SHBG (0.48) | SHBG | |
| SCHEMBL2147382 | 0.70 | CA2 (0.35) | — | |
| SCHEMBL22388295 | 0.68 | CTSK (0.36) | — | |
| SCHEMBL28654671 | 0.67 | ALDH1A1 (0.33) | — | |
| SCHEMBL3367991 | 0.67 | OR51E2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970044-B1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AG (DE) | 2003-05-07 | — | — | EP | disclosed |
| US-6410486-B2 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-25 | — | — | US | disclosed |
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | WETTERICH FRANK (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6265447-B1 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-24 | — | — | US | disclosed |
| EP-0970044-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998041499-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | CBR3, CYCS, CBR1 | SHBG 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.